Senior insider sale
EVP, CFO & CBO at DIANTHUS THERAPEUTICS, INC. /DE/ — senior position signals high conviction
$1.58M
40K shares
What this filing means
SAVITZ RYAN plans to sell 40K shares of DIANTHUS THERAPEUTICS, INC. /DE/ valued at approximately $1.58M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/4/2025ACC: 0001950047-25-009805
Officer· EVP, CFO & CBO
Since Feb 2026
40K
Shares to sell
$1.58M
Approx. market value
20K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
12/4/2025
20KTotal acquired20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/4/2025 | Exercise of Stock Options Cash | 20K | — |
| Total | 20K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
20K
Market value
$700.0K
9/9/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
20K
Market value
$879.4K
12/4/2025
Total
Units
40K
Value
$1.58M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/9/2025 | 20K | $700.0K | — | Completed |
| Planned — Approximate Date | ||||
12/4/2025 | 20K | $879.4K | NASDAQ | Planned |
| Total | 40K | $1.58M | ||